Deepia today joins the France Biotech association, which brings together innovation entrepreneurs in the healthcare sector and their partners.

Our membership reflects the ecosystem’s confidence in Deepia’s disruptive innovation. We are developing the first SaaS platform to enable comprehensive interpretation of medical biology, thanks to our artificial intelligence algorithms, designed and validated with a wide panel of experts in biology and medicine.

This membership will enable us to be at the heart of the healthcare innovation ecosystem and further accelerate our development. Thank you France Biotech!